Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Laurence H. Brinckerhoff
Sign up to set email alerts
25
Publications
219
Citation Statements Received
317
Citation Statements Given
How they've been cited
343
5
214
0
How they cite others
693
8
306
3
Affiliations
University of Virginia
,
Tufts Medical Center
Publications
Order By: Most citations
Terminal modifications inhibit proteolytic degradation of an immunogenic mart-127-35 peptide: Implications for peptide vaccines
Brinckerhoff
1
,
Калашников
2
,
Thompson
3
et al.
1999
Int. J. Cancer
164
5
104
0
Get access via publisher
Add to collection
Cite
Secondary pulmonary alveolar proteinosis in hematologic malignancies
Chaulagain
1
,
Pilichowska
2
,
Brinckerhoff
3
et al.
2014
Abstract
Show
56
0
42
0
Get access via publisher
Add to collection
Cite
Melanoma vaccines
Brinckerhoff
1
,
Thompson
2
,
Slingluff
3
2000
Current Opinion in Oncology
Abstract
Show
46
0
29
0
Get access via publisher
Add to collection
Cite
Pseudomonas Exotoxin-Mediated Delivery of Exogenous Antigens to MHC Class I and Class II Processing Pathways
Lippolis
1
,
Denis-Mize
2
,
Brinckerhoff
3
et al.
2000
Cellular Immunology
17
0
10
0
Get access via publisher
Add to collection
Cite
Preventing the Spontaneous Modification of an HLA-A2-Restricted Peptide at an N-Terminal Glutamine or an Internal Cysteine Residue Enhances Peptide Antigenicity
Thompson
1
,
Hogan
2
,
Caldwell
3
et al.
2004
Journal of Immunotherapy
Abstract
Show
11
0
10
0
Get access via publisher
Add to collection
Cite
Competition Among Peptides in Melanoma Vaccines for Binding to MHC Molecules
Thompson
1
,
Garbee
2
,
Hibbitts
3
et al.
2004
Journal of Immunotherapy
Abstract
Show
15
0
8
0
Get access via publisher
Add to collection
Cite
Vaccination for melanoma
Thompson
1
,
Brinckerhoff
2
,
Slingluff
3
2000
Curr Oncol Rep
Abstract
Show
10
0
5
0
Get access via publisher
Add to collection
Cite
Activated α2-Macroglobulin Reverses the Immunosuppressive Activity in Human Breast Cancer Cell-Conditioned Medium by Selectively Neutralizing Transforming Growth Factor-β in the Presence of Interleukin-2
Harthun
1
,
Weaver
2
,
Brinckerhoff
3
et al.
1998
Journal of Immunotherapy
18
0
5
0
Get access via publisher
Add to collection
Cite
1
2
3